C81.46

Clinical Causes: Genetic factors may predispose individuals to Hodgkin lymphoma. Previous exposure to certain viruses, such as Epstein-Barr virus (EBV), has been associated with increased risk. Family history of lymphoma or other lymphatic system cancers. Immune system suppression due to medical conditions or treatments. Environmental exposures, although evidence is limited, might contribute.

Key Symptoms: Swelling or painless lumps in the groin, pelvis, or abdominal area due to enlarged lymph nodes. Persistent abdominal or pelvic pain or discomfort. Unexplained weight loss over a short period. Fever that comes and goes without an apparent reason. Night sweats leading to soaking sleepwear or bedding. Fatigue and weakness that develop gradually. Itching or skin sensitivity in affected areas. Bowel or urinary disturbances if the disease affects nearby structures.

Diagnosis Path: Physical examination focusing on lymph nodes and abdominal area. Imaging tests like ultrasound, computed tomography (CT), or positron emission tomography (PET) scans to locate enlarged lymph nodes. Lymph node biopsy: An excisional or core biopsy provides tissue samples for microscopic examination. Histopathological analysis identifies characteristic Reed-Sternberg cells and assesses lymphocyte abundance. Immunophenotyping and molecular studies may be used to confirm the diagnosis and rule out other similar conditions.

Treatment Protocols: Chemotherapy: Systemic anti-cancer drugs are frequently used, often involving regimens like ABVD (adriamycin, bleomycin, vinblastine, dacarbazine). Radiation therapy: Targeted radiation to affected lymph nodes may be used in early stages or after chemotherapy for consolidation. Immunotherapy: Newer treatments using immune checkpoint inhibitors are being explored for specific cases. Stem cell transplant: Reserved for refractory or relapsed cases where traditional therapies are ineffective. Supportive care: Managing side effects of treatment and supporting overall well-being is crucial.